Multiple Myeloma is a type of cancer that affects the bone marrow. The disease usually begins in the bone marrow or the lymph nodes in the bones and progresses to the lung using the blood. Multiple myeloma can be called a kind of cancer that starts in another part of the body, such as the bones or the organs. Chemotherapy is used to fight multiple myeloma. A person who has multiple myeloma should therefore receive several different treatments to control the disease.
At this stage, a patient needs to consult with a multiple myeloma specialist to obtain the correct multiple myeloma drugs. An oncology specialist is one of the medical doctors that can do so. The oncology specialist will conduct a bone marrow test to confirm if the disease has indeed spread to the bone marrow. Based on the bone marrow test results, the oncology specialist may then determine the best course of action in combating multiple myeloma.
NIAID (orfavirenzasate) is a drug that is usually given intravenously to people with multiple myeloma. It is known to kill cancer cells in the bone marrow. This drug has already been approved by the Food and Drug Administration. A lot of doctors prescribe multiple myeloma drugs to patients with bone marrow cancer. Even though NIAID is known to be effective in killing cancer cells, it may not be effective against all types of multiple myeloma.
After multiple myeloma diagnoses, the oncology specialist may then present several treatment options for the disease. Surgery is among the treatment options. Although surgery is highly recommended by many doctors, it is not ideal for everyone. Surgery for people with myeloma is usually only done if the oncology specialist feels that there is no other way to cure cancer. Surgery is also one of the most expensive treatment options available for multiple myeloma. Long-term care facilities offer intensive care for people with chronic diseases. People with conditions like multiple myeloma can stay in this type of care unit for up to six months.
Some people with myeloma decide to treat themselves with prescribed medications and natural treatments. The reason why the Food and Drug Administration (FDA) approves these multiple myeloma drugs is that they were designed to be effective without causing any adverse side effects. The most common drug approved by the FDA is called amitriptyline. This drug is also used to treat high blood pressure, depression, diarrhea, asthma, obesity, glaucoma, hepatitis B and C, leukemia, and multiple sclerosis.
The other drug which one should consider taking is known as lenalidomide. This drug is taken to target the cancer cells called the plasma cells. The drug that is normally used to kill cancer cells is called the trichostatin metabolite. However, according to studies conducted by the National Cancer Institute, it was found that the combination of lenalidomide and a single serotonin receptor antagonist can increase the efficacy of the treatment known as "treating patients with myeloma". In this treatment, the combination of the trichostatin metabolite and lenalidomide is used to increase the effectiveness of the drug called "dexamethasone" which is normally used in the treatment of Multiple Myeloma.